2014
DOI: 10.1016/j.lfs.2014.04.035
|View full text |Cite
|
Sign up to set email alerts
|

Cardioprotective effect of embelin on isoproterenol-induced myocardial injury in rats: Possible involvement of mitochondrial dysfunction and apoptosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 47 publications
(24 citation statements)
references
References 29 publications
0
24
0
Order By: Relevance
“…This may determine that Nrf2, upon embelin treatment, isolates from Keap1 protein and consequently translocates to the nucleus. Parallel to our conclusion, earlier research works also established that embelin offers a protective effect against isoproterenol‐induced acute myocardial injury by stimulating the Nrf2 pathway .…”
Section: Discussionmentioning
confidence: 99%
“…This may determine that Nrf2, upon embelin treatment, isolates from Keap1 protein and consequently translocates to the nucleus. Parallel to our conclusion, earlier research works also established that embelin offers a protective effect against isoproterenol‐induced acute myocardial injury by stimulating the Nrf2 pathway .…”
Section: Discussionmentioning
confidence: 99%
“…Rats were randomized into five groups ( n = 6): group (1), normal control rats received dd H 2 O by gavage for a month before subcutaneous injection of physiological saline for two successive days; group (2), ISO control rats received dd H 2 O by oral gavage for a month before subcutaneous injection of ISO (85 mg/kg/day) for two successive days; group (3): acrolein + ISO rats received dd H 2 O by gavage for 28 days, then the rats received acrolein (5 mg/kg/day) by gavage for two days before subcutaneous injection of ISO (85 mg/kg/day) for two successive days; group (4) and (5), rats received OLE at 200 mg/kg/day and 400 mg/kg/day for 28 days, then the rats received acrolein (5 mg/kg/day) by gavage for two days before subcutaneous injection of ISO (85 mg/kg/day) for two successive days. The animals were killed, and the blood and tissue samples were taken after injection of ISO for 48 h. Many studies reported that ISO (85 mg/kg/day) was used to induce MI [ 52 , 53 , 54 ]. Besides, ISO was detected at the different concentrations (5 mg/kg/day, 40 mg/kg/day, 85 mg/kg/day) to induce MI in our pilot experiment and the results indicated that ISO at 85 mg/kg/day presented the clearest effects on inducing MI.…”
Section: Methodsmentioning
confidence: 99%
“…In addition, it reduced apoptosis by downregulating Bax, cytochrome c, caspase‐3, caspase‐9, poly ADP ribose polymerase (PARP), and enhanced the expression of Bcl‐2. Moreover, embelin pretreatment considerably decreased the pathological changes such as loss of myofibrillar alignment, myocardial degeneration, severe cytoplasmic vacuolization, and infiltration of inflammatory cells when compared with only ISP administered rats (Sahu et al, ). Kocak et al () reported similar cardioprotective effects of embelin and carnosic acid via modulation of NFκB‐Nrf‐2‐MAPK pathway.…”
Section: Natural Products and Their Pharmacological Potential In Allementioning
confidence: 99%